ADVENTRX Pharmaceuticals to Present at the BIOCOM Investor Conference on October 26

SAN DIEGO, Oct. 15  /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that the Company's Principal Executive Officer, Brian M. Culley, will present at the BIOCOM Investor Conference on Monday, October 26, 2009, at 10:00 a.m. Pacific time, at the Hyatt Regency in La Jolla, California.

Interested parties can access a live audio webcast and slide presentation on the ADVENTRX Pharmaceuticals Web site at http://www.adventrx.com/.  An archived presentation will be available on the Web site for 30 days.

About ADVENTRX Pharmaceuticals

ADVENTRX Pharmaceuticals is a specialty pharmaceutical company whose product candidates are designed to improve the safety of existing cancer treatments.  More information can be found on the Company's web site at http://www.adventrx.com/. 

DATASOURCE: ADVENTRX Pharmaceuticals, Inc.



CONTACT:  Brian Culley, Principal Executive Officer of ADVENTRX

Pharmaceuticals, [phone]; or Investors, Don Markley of

Lippert/Heilshorn & Associates, Inc., [phone], , for

ADVENTRX Pharmaceuticals



Web Site:  http://www.adventrx.com/ 

Copyright